BTLS — Biotalys NV Income Statement
0.000.00%
Last trade - 00:00- €165.46m
- €151.93m
Annual income statement for Biotalys NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 13.3 | 18.1 | 22.5 | 20.9 | 13.5 |
| Operating Profit | -13.3 | -18.1 | -22.5 | -20.9 | -13.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -10.7 | -16.9 | -22.8 | -20.5 | -13.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -10.8 | -16.9 | -22.7 | -20.5 | -13.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -10.8 | -16.9 | -22.7 | -20.5 | -13.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -10.8 | -16.9 | -22.7 | -20.5 | -13.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.358 | -1.1 | -0.736 | -0.649 | -0.397 |
| Dividends per Share |